- Titre
- Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England (sep, 10.1007/s12325-025-03349-7, 2025)
- Créateurs - sans rôle
- Ashley Woodcock - University of ManchesterJohn Blakey - Sir Charles Gairdner Hosp, Resp Med, Perth, WA, AustraliaArnaud Bourdin - InsermGiorgio Walter Canonica - Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20072 Pieve Emanuele, Milan, ItalyChristian Domingo - Institute of Research and Innovation Parc TauliAlexander Ford - Adelphi Real World, Bollington, EnglandRosie Hulme - Adelphi Real World, Bollington, EnglandTheo Tritton - Adelphi Real World, Bollington, EnglandInes Palomares - GSK, Global Hlth, RWE & Hlth Outcomes Res, Madrid, SpainSanchayita Sadhu - GSK, Biostat, Bangalore, IndiaArunangshu Biswas - GSK, Biostat, Bangalore, IndiaManish Verma - GSK, Global Med Affairs, Gen Med, GSK House,Dr Annie Besant Rd, Mumbai 400030, India
- Détails de publication
- Advances in therapy, Vol.42(12), pp.5978-5979
- Éditeur
- Springer Nature
- Nombre de pages
- 2
- Identifiants
- 99158908009311
- Unité académique
- Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England (sep, 10.1007/s12325-025-03349-7, 2025)
Advances in therapy, Vol.42(12), pp.5978-5979
01/12/2025
PMID: 41175324
Indicateurs
1 Consultations de la notice